Cell MedX Corp. Share Price

Equities

CMXC

US15115X1072

Biotechnology & Medical Research

Market Closed - OTC Markets 09:25:18 25/04/2024 pm IST 5-day change 1st Jan Change
0.032 USD -25.58% Intraday chart for Cell MedX Corp. -33.33% +45.45%
Sales 2022 0.01 0.51 Sales 2023 0 0.23 Capitalization 6.29K 525K
Net income 2022 - 0 Net income 2023 - 0 EV / Sales 2022 1,13,51,53,669 x
Net Debt 2022 592K 49.39M Net Debt 2023 903K 75.27M EV / Sales 2023 32,91,16,944 x
P/E ratio 2022
-9.01 x
P/E ratio 2023
-0.01 x
Employees 1
Yield 2022 *
-
Yield 2023
-
Free-Float 20.34%
More Fundamentals * Assessed data
Dynamic Chart
1 day-25.58%
1 week-33.33%
Current month+7.74%
1 month+33.33%
3 months+3.23%
6 months-9.86%
Current year+45.45%
More quotes
1 week
0.03
Extreme 0.032
0.05
1 month
0.02
Extreme 0.015
0.05
Current year
0.01
Extreme 0.0105
0.23
1 year
0.00
Extreme 0
0.93
3 years
0.00
Extreme 0
0.93
5 years
0.00
Extreme 0
1.69
10 years
0.00
Extreme 0
1.69
More quotes
Managers TitleAgeSince
Chief Executive Officer 54 12/12
Director of Finance/CFO 45 24/14/24
Chairman 76 23/18/23
Members of the board TitleAgeSince
Chief Executive Officer 54 12/12
Director/Board Member 63 27/22/27
Director/Board Member 59 08/20/08
More insiders
Date Price Change Volume
25/24/25 0.032 -25.58% 19,200
24/24/24 0.043 +22.86% 10,020
23/24/23 0.035 -5.41% 178,847
22/24/22 0.037 -22.92% 39,279
19/24/19 0.048 0.00% 15,730

Delayed Quote OTC Markets, April 25, 2024 at 09:25 pm IST

More quotes
Cell MedX Corp. is a biotechnology company. It is focused on the discovery, development and commercialization of therapeutic and non-therapeutic products that promote general wellness, general health, pain relief, wellness and alleviate complications associated with medical conditions including, diabetes, Parkinson’s disease, high blood pressure, neuropathy, and kidney function. The Company, through its subsidiary, is engaged in developing and manufacturing therapeutic devices based on its eBalance technology, which harnesses the power of microcurrents and its effects on the human body. The eBalance Pro System and eBalance Home System, are microcurrent electrotherapy systems intended to administer a specific variety of therapeutic microcurrent algorithms for temporary relief of pain associated with sore/aching muscles in the shoulders, waist, back, neck, upper extremities (arms) and lower extremities. Its Microcurrent therapy uses molecular bioelectricity in cell-to-cell signaling.
More about the company